Additionally, studies have demonstrated that SOX2 contributes to the progression of laryngeal cancer, where it exerts crucial regulatory effects on apoptosis and metastasis of laryngeal cancer cells through the MAP4K4/JNK signaling pathway [64]. This evidence concerns the gene MAP4K4 and laryngeal carcinoma.